Quality of life in patients with brain metastases treated with a palliative course of whole-brain radiotherapy

J Palliat Med. 2007 Apr;10(2):367-74. doi: 10.1089/jpm.2006.0202.

Abstract

Background: The primary objective of this study was to assess whether there was an improvement in quality of life for patients with brain metastases as measured 1 and 2 months after a course of whole-brain radiotherapy. The secondary objective was to assess the level of agreement between patient and proxy quality of life scores.

Methods and materials: Sixty patients with brain metastases and their proxy completed the Functional Assessment of Cancer Therapy-Brain (FACT-BR) questionnaire independently. Proxies were given instructions to answer from the patient's perspective. Quality-of-life assessments were conducted at baseline, 1 month, and 2 months after completion of whole-brain radiotherapy. Paired t tests with Bonferroni adjustment for multiple comparisons were calculated to detect significant differences in global quality-of-life scores. Lin's concordance correlation coefficient measured agreement between patient and proxy quality-of-life ratings.

Results: No significant difference was detected in overall quality of life after whole-brain radiotherapy. At 2 months after whole-brain radiotherapy, there was a trend toward worsening general and brain specific quality-of-life scores. There was poor concordance between patients and their proxies for all quality-of-life domains at baseline.

Conclusion: At 2 months after whole-brain radiotherapy, there was a trend toward worsening general and brain specific quality-of-life scores. Proxy rating of patients' quality of life showed poor concordance at baseline.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Brain Neoplasms / drug therapy
  • Brain Neoplasms / physiopathology
  • Brain Neoplasms / radiotherapy*
  • Cancer Care Facilities
  • Dexamethasone / therapeutic use
  • Feasibility Studies
  • Female
  • Humans
  • Karnofsky Performance Status
  • Male
  • Middle Aged
  • Palliative Care*
  • Proxy
  • Psychometrics*
  • Quality of Life / psychology*
  • Radiation Oncology / methods*
  • Surveys and Questionnaires
  • Treatment Outcome

Substances

  • Antineoplastic Agents, Hormonal
  • Dexamethasone